{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:38:21Z","timestamp":1777095501909,"version":"3.51.4"},"reference-count":73,"publisher":"University of Tokushima Faculty of Medicine","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2152\/jmi.73.1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:10:05Z","timestamp":1776895805000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["New approaches to the diagnosis and treatment of atrial fibrillation"],"prefix":"10.2152","volume":"73","author":[{"given":"Takeshi","family":"Soeki","sequence":"first","affiliation":[{"name":"Division of Cardiology and Arrhythmia, Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"},{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Tezuka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S:Prevalence of atrial fibrillation in the general population of Japan:an analysis based on periodic health examination. Int J Cardiol 137(2):102-7, 2009","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D\u2019Agostino RB, Sr., Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ:Development of a risk score for atrial fibrillation (Framingham Heart Study):a community-based cohort study. Lancet 373(9665):739-45, 2009","DOI":"10.1016\/S0140-6736(09)60443-8"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A:Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors:the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123(14):1501-8, 2011","DOI":"10.1161\/CIRCULATIONAHA.110.009035"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR:C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104(24):2886-91, 2001","DOI":"10.1161\/hc4901.101760"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Roldan V, Marin F, Blann AD, Garcia A, Marco P, Sogorb F, Lip GY:Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24(14):1373-80, 2003","DOI":"10.1016\/S0195-668X(03)00239-2"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK:Inflammation as a risk factor for atrial fibrillation. Circulation 108(24):3006-10, 2003","DOI":"10.1161\/01.CIR.0000103131.70301.4F"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamashita T, Sekiguchi A, Iwasaki YK, Date T, Sagara K, Tanabe H, Suma H, Sawada H, Aizawa T:Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 74(2):262-70, 2010","DOI":"10.1253\/circj.CJ-09-0644"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hagiwara N:Inflammation and atrial fibrillation. Circ J 74(2):246-7, 2010","DOI":"10.1253\/circj.CJ-09-0986"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gabay C, Kushner I:Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448-54, 1999","DOI":"10.1056\/NEJM199902113400607"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ommen SR, Odell JA, Stanton MS:Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336(20):1429-34, 1997","DOI":"10.1056\/NEJM199705153362006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dernellis J, Panaretou M:Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25(13):1100-7, 2004","DOI":"10.1016\/j.ehj.2004.04.025"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P, Nakauchi H, Nakaya H, Komuro I:Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120(1):242-53, 2010","DOI":"10.1172\/JCI39942"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didie M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann WH, Meinertz T, Boger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, Baldus S:Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16(4):470-4, 2010","DOI":"10.1038\/nm.2124"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S:A Toll-like receptor recognizes bacterial DNA. Nature 408(6813):740-5, 2000","DOI":"10.1038\/35047123"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yasuda K, Richez C, Uccellini MB, Richards RJ, Bonegio RG, Akira S, Monestier M, Corley RB, Viglianti GA, Marshak-Rothstein A, Rifkin IR:Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J Immunol 183(5):3109-17, 2009","DOI":"10.4049\/jimmunol.0900399"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fukuda D, Nishimoto S, Aini K, Tanaka A, Nishiguchi T, Kim-Kaneyama JR, Lei XF, Masuda K, Naruto T, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Imoto I, Akasaka T, Shimabukuro M, Sata M:Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis. J Am Heart Assoc 8(7):e010860, 2019","DOI":"10.1161\/JAHA.118.010860"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wiersma M, van Marion DMS, Bouman EJ, Li J, Zhang D, Ramos KS, Lanters EAH, de Groot NMS, Brundel B:Cell-Free Circulating Mitochondrial DNA:A Potential Blood-Based Marker for Atrial Fibrillation. Cells 9(5):2020","DOI":"10.3390\/cells9051159"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamazoe M, Sasano T, Ihara K, Takahashi K, Nakamura W, Takahashi N, Komuro H, Hamada S, Furukawa T:Sparsely methylated mitochondrial cell free DNA released from cardiomyocytes contributes to systemic inflammatory response accompanied by atrial fibrillation. Sci Rep 11(1):5837, 2021","DOI":"10.1038\/s41598-021-85204-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Miyamoto S, Tokuyama T, Okubo Y, Okamura S, Miyauchi S, Furutani M, Kobayashi Y, Odake Y, Oguri N, Uotani Y, Nakashima M, Akiyama R, Sakai T, Ishida M, Nakano Y:Decreased plasma cell-free mitochondrial DNA may be a new biomarker of tachycardia-induced cardiomyopathy in patients with atrial fibrillation. Int J Cardiol 417:132579, 2024","DOI":"10.1016\/j.ijcard.2024.132579"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pool L, van Wijk SW, van Schie MS, Taverne Y, de Groot NMS, Brundel B:Quantifying DNA Lesions and Circulating Free DNA:Diagnostic Marker for Electropathology and Clinical Stage of AF. JACC Clin Electrophysiol 11(2):321-32, 2025","DOI":"10.1016\/j.jacep.2024.10.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Guo Y, Lip GY, Apostolakis S:Inflammation in atrial fibrillation. J Am Coll Cardiol 60(22):2263-70, 2012","DOI":"10.1016\/j.jacc.2012.04.063"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dernellis J, Panaretou M:C-reactive protein and paroxysmal atrial fibrillation:evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 56(6):375-80, 2001","DOI":"10.2143\/AC.56.6.2005701"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE:Interleukin-6 and atrial fibrillation in patients with coronary artery disease:data from the Heart and Soul Study. Am Heart J 155(2):303-9, 2008","DOI":"10.1016\/j.ahj.2007.09.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Amdur RL, Mukherjee M, Go A, Barrows IR, Ramezani A, Shoji J, Reilly MP, Gnanaraj J, Deo R, Roas S, Keane M, Master S, Teal V, Soliman EZ, Yang P, Feldman H, Kusek JW, Tracy CM, Raj DS, Investigators CS:Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease:Findings from the CRIC Study. PLoS One 11(2):e0148189, 2016","DOI":"10.1371\/journal.pone.0148189"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Aulin J, Siegbahn A, Hijazi Z, Ezekowitz MD, Andersson U, Connolly SJ, Huber K, Reilly PA, Wallentin L, Oldgren J:Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J 170(6):1151-60, 2015","DOI":"10.1016\/j.ahj.2015.09.018"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Garlanda C, Bottazzi B, Bastone A, Mantovani A:Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23:337-66, 2005","DOI":"10.1146\/annurev.immunol.23.021704.115756"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M:Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels 29(5):653-8, 2014","DOI":"10.1007\/s00380-013-0400-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O\u2019Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M:Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513-8, 2008","DOI":"10.1073\/pnas.0804549105"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Soeki T, Yamaguchi K, Niki T, Uematsu E, Bando S, Matsuura T, Ise T, Kusunose K, Hotchi J, Tobiume T, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M:Plasma microRNA-100 is associated with coronary plaque vulnerability. Circ J 79(2):413-8, 2015","DOI":"10.1253\/circj.CJ-14-0958"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. De Rosa S, Curcio A, Indolfi C:Emerging role of microRNAs in cardiovascular diseases. Circ J 78(3):567-75, 2014","DOI":"10.1253\/circj.CJ-14-0086"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wang Z, Lu Y, Yang B:MicroRNAs and atrial fibrillation:new fundamentals. Cardiovasc Res 89(4):710-21, 2011","DOI":"10.1093\/cvr\/cvq350"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Soeki T, Matsuura T, Bando S, Tobiume T, Uematsu E, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M:Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. J Cardiol 68(6):472-7, 2016","DOI":"10.1016\/j.jjcc.2015.12.007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ye X, Wang Z, Lei W, Shen M, Tang J, Xu X, Yang Y, Zhang H:Pentraxin 3:A promising therapeutic target for cardiovascular diseases. Ageing Res Rev 93:102163, 2024","DOI":"10.1016\/j.arr.2023.102163"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cisneros-Villanueva M, Hidalgo-Perez L, Rios-Romero M, Cedro-Tanda A, Ruiz-Villavicencio CA, Page K, Hastings R, Fernandez-Garcia D, Allsopp R, Fonseca-Montano MA, Jimenez-Morales S, Padilla-Palma V, Shaw JA, Hidalgo-Miranda A:Cell-free DNA analysis in current cancer clinical trials:a review. Br J Cancer 126(3):391-400, 2022","DOI":"10.1038\/s41416-021-01696-0"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Vaziri SM, Larson MG, Benjamin EJ, Levy D:Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89(2):724-30, 1994","DOI":"10.1161\/01.CIR.89.2.724"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB:Risks for atrial fibrillation and congestive heart failure in patients >\/=65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol 93(1):54-8, 2004","DOI":"10.1016\/j.amjcard.2003.09.012"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB:Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40(9):1636-44, 2002","DOI":"10.1016\/S0735-1097(02)02373-2"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A:Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121(17):1904-11, 2010","DOI":"10.1161\/CIRCULATIONAHA.109.874982"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Chong BH, Pong V, Lam KF, Liu S, Zuo ML, Lau YF, Lau CP, Tse HF, Siu CW:Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. Europace 14(7):942-7, 2012","DOI":"10.1093\/europace\/eur389"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M:Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation. Circ J 82(9):2253-8, 2018","DOI":"10.1253\/circj.CJ-17-0758"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kaab S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ:Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population:the CHARGE-AF consortium. J Am Heart Assoc 2(2):e000102, 2013","DOI":"10.1161\/JAHA.112.000102"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Christophersen IE, Yin X, Larson MG, Lubitz SA, Magnani JW, McManus DD, Ellinor PT, Benjamin EJ:A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. Am Heart J 178:45-54, 2016","DOI":"10.1016\/j.ahj.2016.05.004"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, Carter RE, Yao X, Rabinstein AA, Erickson BJ, Kapa S, Friedman PA:An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm:a retrospective analysis of outcome prediction. Lancet 394(10201):861-7, 2019","DOI":"10.1016\/S0140-6736(19)31721-0"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Noseworthy PA, Attia ZI, Behnken EM, Giblon RE, Bews KA, Liu S, Gosse TA, Linn ZD, Deng Y, Yin J, Gersh BJ, Graff-Radford J, Rabinstein AA, Siontis KC, Friedman PA, Yao X:Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm:a prospective non-randomised interventional trial. Lancet 400(10359):1206-12, 2022","DOI":"10.1016\/S0140-6736(22)01637-3"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Yuan N, Duffy G, Dhruva SS, Oesterle A, Pellegrini CN, Theurer J, Vali M, Heidenreich PA, Keyhani S, Ouyang D:Deep Learning of Electrocardiograms in Sinus Rhythm From US Veterans to Predict Atrial Fibrillation. JAMA Cardiol 8(12):1131-9, 2023","DOI":"10.1001\/jamacardio.2023.3701"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Kim YR, Nam GB, Han S, Kim SH, Kim KH, Lee S, Kim J, Choi KJ, Kim YH:Effect of Short-Term Steroid Therapy on Early Recurrence During the Blanking Period After Catheter Ablation of Atrial Fibrillation. Circ Arrhythm Electrophysiol 8(6):1366-72, 2015","DOI":"10.1161\/CIRCEP.115.002957"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Prasongsukarn K, Abel JG, Jamieson WR, Cheung A, Russell JA, Walley KR, Lichtenstein SV:The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery:a prospective randomized trial. J Thorac Cardiovasc Surg 130(1):93-8, 2005","DOI":"10.1016\/j.jtcvs.2004.09.014"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Kaoukis A, Raisakis K, Bouras G, Angelidis C, Theodorakis A, Driva M, Doudoumis K, Pyrgakis V, Stefanadis C:Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation:a randomized controlled study. J Am Coll Cardiol 60(18):1790-6, 2012","DOI":"10.1016\/j.jacc.2012.07.031"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, Caforio AL, Cemin R, Chirillo F, Comoglio C, Cugola D, Cumetti D, Dyrda O, Ferrua S, Finkelstein Y, Flocco R, Gandino A, Hoit B, Innocente F, Maestroni S, Musumeci F, Oh J, Pergolini A, Polizzi V, Ristic A, Simon C, Spodick DH, Tarzia V, Trimboli S, Valenti A, Belli R, Gaita F, Investigators C-:Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation:the COPPS-2 randomized clinical trial. JAMA 312(10):1016-23, 2014","DOI":"10.1001\/jama.2014.11026"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Fang WT, Li HJ, Zhang H, Jiang S:The role of statin therapy in the prevention of atrial fibrillation:a meta-analysis of randomized controlled trials. Br J Clin Pharmacol 74(5):744-56, 2012","DOI":"10.1111\/j.1365-2125.2012.04258.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, Derian CK, Andrade-Gordon P, Rosen H, Ruf W:Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452(7187):654-8, 2008","DOI":"10.1038\/nature06663"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Badeanlou L, Furlan-Freguia C, Yang G, Ruf W, Samad F:Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat Med 17(11):1490-7, 2011","DOI":"10.1038\/nm.2461"},{"key":"53","doi-asserted-by":"publisher","unstructured":"53. Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M:Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis 242(2):639-46, 2015","DOI":"10.1016\/j.atherosclerosis.2015.03.023"},{"key":"54","doi-asserted-by":"publisher","unstructured":"54. Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Imoto I, Shimabukuro M, Sata M:Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation 138(16):1706-19, 2018","DOI":"10.1161\/CIRCULATIONAHA.118.033544"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Antoniak S, Rojas M, Spring D, Bullard TA, Verrier ED, Blaxall BC, Mackman N, Pawlinski R:Protease-activated receptor 2 deficiency reduces cardiac ischemia\/reperfusion injury. Arterioscler Thromb Vasc Biol 30(11):2136-42, 2010","DOI":"10.1161\/ATVBAHA.110.213280"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Yasuda S, Ogawa H, Investigators A:Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Reply. N Engl J Med 381(25):2481, 2019","DOI":"10.1056\/NEJMc1914049"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Matsuura T, Soeki T, Fukuda D, Uematsu E, Tobiume T, Hara T, Kusunose K, Ise T, Yamaguchi K, Yagi S, Yamada H, Wakatsuki T, Sata M:Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation. Circ J 85(8):1383-91, 2021","DOI":"10.1253\/circj.CJ-20-1006"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA:Atrial fibrillation and risks of cardiovascular disease, renal disease, and death:systematic review and meta-analysis. BMJ 354:i4482, 2016","DOI":"10.1136\/bmj.i4482"},{"key":"59","doi-asserted-by":"publisher","unstructured":"59. Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S, Investigators R-L:Causes of death and influencing factors in patients with atrial fibrillation:a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation 128(20):2192-201, 2013","DOI":"10.1161\/CIRCULATIONAHA.112.000491"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Batul SA, Gopinathannair R:Atrial Fibrillation in Heart Failure:a Therapeutic Challenge of Our Times. Korean Circ J 47(5):644-62, 2017","DOI":"10.4070\/kcj.2017.0040"},{"key":"61","doi-asserted-by":"publisher","unstructured":"61. Yamashita Y, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M:Clinical Characteristics and Outcomes in Extreme Elderly (Age >\/= 85 Years) Japanese Patients With Atrial Fibrillation:The Fushimi AF Registry. Chest 149(2):401-12, 2016","DOI":"10.1378\/chest.15-1095"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Tani A, Soeki T, Suto K, Ozaki Y, Aihara KI, Sata M: Impact of Atrial Fibrillation Accompanied by Sarcopenia and Cellular Edema on the Prevalence of Heart Failure in Elderly Individuals. Int Heart J 66(5):780-5, 2025","DOI":"10.1536\/ihj.25-201"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Boengler K, Kosiol M, Mayr M, Schulz R, Rohrbach S: Mitochondria and ageing:role in heart, skeletal muscle and adipose tissue. J Cachexia Sarcopenia Muscle 8(3):349-69, 2017","DOI":"10.1002\/jcsm.12178"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Harada M, Tadevosyan A, Qi X, Xiao J, Liu T, Voigt N, Karck M, Kamler M, Kodama I, Murohara T, Dobrev D, Nattel S:Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling:Potential Role in Metabolic Adaptation and Prevention of Progression. J Am Coll Cardiol 66(1):47-58, 2015","DOI":"10.1016\/j.jacc.2015.04.056"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Yang E, Rashid H:Heart failure with preserved ejection fraction and atrial fibrillation:clinical management in the context of recent therapeutic advances in heart failure and electrophysiology. Front Cardiovasc Med 11:1349584, 2024","DOI":"10.3389\/fcvm.2024.1349584"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O\u2019Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial F, Congestive Heart Failure I:Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358(25):2667-77, 2008","DOI":"10.1056\/NEJMoa0708789"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Al Halabi S, Qintar M, Hussein A, Alraies MC, Jones DG, Wong T, MacDonald MR, Petrie MC, Cantillon D, Tarakji KG, Kanj M, Bhargava M, Varma N, Baranowski B, Wilkoff BL, Wazni O, Callahan T, Saliba W, Chung MK:Catheter Ablation for Atrial Fibrillation in Heart Failure Patients:A Meta-Analysis of Randomized Controlled Trials. JACC Clin Electrophysiol 1(3):200-9, 2015","DOI":"10.1016\/j.jacep.2015.02.018"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D, Investigators C-A:Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 378(5):417-27, 2018","DOI":"10.1056\/NEJMoa1707855"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Gutman SJ, Lee G, Layland J, Mariani JA, Ling LH, Kalman JM, Kistler PM:Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction:The CAMERA-MRI Study. J Am Coll Cardiol 70(16):1949-61, 2017","DOI":"10.1016\/j.jacc.2017.08.041"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Benali K, Khairy P, Hammache N, Petzl A, Da Costa A, Verma A, Andrade JG, Macle L:Procedure-Related Complications of Catheter Ablation for Atrial Fibrillation. J Am Coll Cardiol 81(21):2089-99, 2023","DOI":"10.1016\/j.jacc.2023.03.418"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Rubinsky B, Onik G, Mikus P:Irreversible electroporation:a new ablation modality--clinical implications. Technol Cancer Res Treat 6(1):37-48, 2007","DOI":"10.1177\/153303460700600106"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Maan A, Koruth J:Pulsed Field Ablation:a New Paradigm for Catheter Ablation of Arrhythmias. Curr Cardiol Rep 24(2):103-8, 2022","DOI":"10.1007\/s11886-021-01630-z"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel C, Mountantonakis SE, Gibson DN, Harding JD, Ellis CR, Ellenbogen KA, DeLurgio DB, Osorio J, Achyutha AB, Schneider CW, Mugglin AS, Albrecht EM, Stein KM, Lehmann JW, Mansour M, Investigators A:Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med 389(18):1660-71, 2023","DOI":"10.1056\/NEJMoa2307291"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/73\/1.2\/73_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:57:02Z","timestamp":1777093022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/73\/1.2\/73_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":73,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.73.1","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}